| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.1853 | 28 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.8293 | 48 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.8004 | 31 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.2627 | 10 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.5128 | 47 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.4149 | 34 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.3583 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.8339 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.6161 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.4318 | 34 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.3224 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 38.3556 | 3 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.6513 | 30 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.478 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 51.0647 | 52 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 38.8527 | 4 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.1862 | 28 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.7684 | 26 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.7965 | 40 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.7811 | 51 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 54.7992 | 59 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.2268 | 28 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.9333 | 58 |